实验动物与比较医学 ›› 2026, Vol. 46 ›› Issue (1): 66-80.DOI: 10.12300/j.issn.1674-5817.2025.060
收稿日期:2025-04-23
修回日期:2025-08-20
出版日期:2026-02-25
发布日期:2026-02-14
通讯作者:
雷爽(1986—),女,博士,副主任中医师,研究方向:中医药防治小儿神经精神系统疾病研究。E-mail:leishuanghaohao@126.com。ORCID: 0009-0006-8523-2880作者简介:廖望钥(2003—),女,本科生,研究方向:中医药防治小儿神经精神系统疾病研究。E-mail: liao_wangyue@163.com基金资助:
LIAO Wangyue, LEI Shuang(
)(
), LI Xuan, GUO Min, ZHOU Ruoran
Received:2025-04-23
Revised:2025-08-20
Published:2026-02-25
Online:2026-02-14
摘要:
注意缺陷多动障碍(attention deficit and hyperactive disorder,ADHD)为儿童期最常见神经发育障碍,严重危害学业、社交与职业发展,并增加意外伤害、物质滥用的发生概率,部分病例的症状还可能间接扰乱社会治安秩序。ADHD的病因涉及遗传、围产期环境与心理社会因素的交互作用,单一临床研究难以厘清机制,系统评估现有动物模型对揭示其病理机制与开发新疗法至关重要。本文检索2000—2025年PubMed、Web of Science、中国知网、万方数据知识服务平台的文献,辅以“注意缺陷多动障碍”“动物模型”“效度”及对应英文词“attention deficit and hyperactive disorder”“models,animal”“validity”(共检索到328篇)追溯引用:纳入啮齿类ADHD模型且含造模方法、行为学、神经机制或药效数据86篇,按自发性遗传模型、基因工程模型、环境诱导模型3大类归纳,从表面效度、结构效度和预测效度3维度横向比较。自发性遗传模型中,自发性高血压大鼠能较好模拟多动、冲动及兴奋剂反应,但高血压并发症和性别差异削弱特异性;无胼胝体鼠种系提示胼胝体缺失与ADHD样行为相关,而神经递质研究仍不足。基因工程模型方面,多巴胺转运体(dopamine transporter)、神经激肽1受体(neurokinin 1 receptor)、中介体复合物亚基23(mediator complex subunit 23)等基因敲除或条件性基因敲除啮齿类动物模型可精准解析多巴胺、去甲肾上腺素、突触蛋白或表观遗传通路,但普遍存在表型覆盖不全、社交缺陷与共病模拟不足的问题,且伴随生长迟缓或眼部缺陷等不良反应。环境诱导模型通过铅、多氯联苯、酒精、尼古丁暴露,或6-羟基多巴胺(6-hydroxydopamine)损毁、新生缺氧、早期社会隔离及母性应激模拟部分核心症状,但剂量-周期标准化欠缺,行为可逆性与临床持续性不符,且常伴焦虑、抑郁等非特异表型。整体而言,尚无单一范式同时具备高表面、结构、预测效度。目前,ADHD模型已从单因素走向多维度评估,但在遗传背景标准化、性别差异、跨物种转化及中医辨证分型建模方面仍存在显著缺口。未来,应整合遗传-环境-表观遗传多因素交互,建立跨生命周期验证体系,并融合计算神经科学与中西医结合策略,以提升ADHD模型的临床关联性与转化应用价值,为机制阐释、新药筛选和精准干预提供更为坚实的循证支撑。
中图分类号:
廖望钥,雷爽,李璇,等. 注意缺陷多动障碍动物模型文献分析及效度评价[J]. 实验动物与比较医学, 2026, 46(1): 66-80. DOI: 10.12300/j.issn.1674-5817.2025.060.
LIAO Wangyue,LEI Shuang,LI Xuan,et al. Literature Analysis and Validity Assessment for Animal Models of Attention Deficit and Hyperactive Disorder[J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 66-80. DOI: 10.12300/j.issn.1674-5817.2025.060.
模型分类 Model classifications | 表面效度 Face validity | 结构效度 Construct validity | 预测效度 Predictive validity |
|---|---|---|---|
自发性高血压型[ Spontaneously hypertensive type[ | 大鼠表现多动、冲动、注意缺陷,均显著 | 模拟ADHD的神经生理机制,如DA系统异常 | 良好 |
无胼胝体鼠种系型[ Acallosal mouse strain type[ | 大鼠表现多动、冲动及注意力缺陷 | 具有与ADHD相关的神经发育异常 | 有限 |
DAT-KO型[ DAT-KO type[ | 大鼠表现自发性多动,空间记忆存在缺陷、认知障碍 | 模拟编码DA转运体的基因缺失导致的神经递质异常 | 有限 |
Lphn3-KO型[ Lphn3-KO type[ | 大鼠表现明显的运动过度与冲动,注意力缺陷未能充分复现 | 模拟编码黏附G蛋白偶联受体L3蛋白的基因缺失导致的神经发育异常 | 有限 |
Snap25-KO型[ Snap25-KO type[ | 小鼠表现多动且学习记忆能力显著缺陷 | 模拟编码突触相关蛋白25的基因缺失导致的神经递质释放障碍 | 有限 |
NK1R-KO型[ NK1R-KO type[ | 小鼠表现出明确的多动行为,冲动、注意缺陷已被证实 | 模拟神经激肽1受体缺失导致的神经调节异常 | 有限 |
COMT-KO型[ COMT-KO type[ | 小鼠表现冲动,有性别差异 | 模拟编码儿茶酚-O-甲基转移酶的基因缺失导致的DA代谢异常 | 有限 |
Fmr1-KO型[ Fmr1-KO type[ | 大鼠注意缺陷显著,伴随孤独症谱系障碍的特征 | 模拟脆性X智力低下1基因缺失导致的神经发育异常 | 有限 |
Med23-CKO型[ Med23-CKO type[ | 小鼠表现多动、注意缺陷、冲动、感觉门控缺陷 | 齿状回发育畸形、突触可塑性损伤 | 有限 |
环境毒素暴露型[ Environmental toxin exposure type[ | 暴露剂量与大鼠/小鼠多动、冲动、注意缺陷呈正相关 | 模拟化学物质暴露导致的神经毒性 | 有限 |
PAE型[ PAE type[ | 大鼠表现多动伴认知迟缓,冲动注意缺陷并存 | 模拟产前酒精暴露导致的神经发育异常 | 有限 |
PNE型[ PNE type[ | 大鼠表现多动突出,注意力缺陷明显 | 模拟产前尼古丁暴露导致的神经发育异常 | 较优 |
6-OHDA损毁型[ 6-OHDA-lesioned type[ | 大鼠的行为表现复杂,具有年龄、性别差异 | 模拟DA能神经元损伤 | 有限 |
新生缺氧型[ Neonatal hypoxia type[ | 大鼠表现出注意力不集中、冲动 | 模拟缺氧导致的神经损伤 | 有限 |
社会隔离型[ Social isolation type[ | 大鼠表现攻击性反应和冲动、过度活跃,认知功能缺陷 | 伏隔核DA增强,5-羟色胺通路受损 | 有限 |
母性应激型[ Maternal stress type[ | 小鼠表现注意力和学习能力的缺陷 | 产前应激致DA、5-羟色胺网络敏感 | 有限 |
表 1 各种注意缺陷多动障碍动物模型的表面效度、结构效度、预测效度总结
Table 1 Summary of face, construct, and predictive validity of various animal models of attention deficit and hyperactive disorder
模型分类 Model classifications | 表面效度 Face validity | 结构效度 Construct validity | 预测效度 Predictive validity |
|---|---|---|---|
自发性高血压型[ Spontaneously hypertensive type[ | 大鼠表现多动、冲动、注意缺陷,均显著 | 模拟ADHD的神经生理机制,如DA系统异常 | 良好 |
无胼胝体鼠种系型[ Acallosal mouse strain type[ | 大鼠表现多动、冲动及注意力缺陷 | 具有与ADHD相关的神经发育异常 | 有限 |
DAT-KO型[ DAT-KO type[ | 大鼠表现自发性多动,空间记忆存在缺陷、认知障碍 | 模拟编码DA转运体的基因缺失导致的神经递质异常 | 有限 |
Lphn3-KO型[ Lphn3-KO type[ | 大鼠表现明显的运动过度与冲动,注意力缺陷未能充分复现 | 模拟编码黏附G蛋白偶联受体L3蛋白的基因缺失导致的神经发育异常 | 有限 |
Snap25-KO型[ Snap25-KO type[ | 小鼠表现多动且学习记忆能力显著缺陷 | 模拟编码突触相关蛋白25的基因缺失导致的神经递质释放障碍 | 有限 |
NK1R-KO型[ NK1R-KO type[ | 小鼠表现出明确的多动行为,冲动、注意缺陷已被证实 | 模拟神经激肽1受体缺失导致的神经调节异常 | 有限 |
COMT-KO型[ COMT-KO type[ | 小鼠表现冲动,有性别差异 | 模拟编码儿茶酚-O-甲基转移酶的基因缺失导致的DA代谢异常 | 有限 |
Fmr1-KO型[ Fmr1-KO type[ | 大鼠注意缺陷显著,伴随孤独症谱系障碍的特征 | 模拟脆性X智力低下1基因缺失导致的神经发育异常 | 有限 |
Med23-CKO型[ Med23-CKO type[ | 小鼠表现多动、注意缺陷、冲动、感觉门控缺陷 | 齿状回发育畸形、突触可塑性损伤 | 有限 |
环境毒素暴露型[ Environmental toxin exposure type[ | 暴露剂量与大鼠/小鼠多动、冲动、注意缺陷呈正相关 | 模拟化学物质暴露导致的神经毒性 | 有限 |
PAE型[ PAE type[ | 大鼠表现多动伴认知迟缓,冲动注意缺陷并存 | 模拟产前酒精暴露导致的神经发育异常 | 有限 |
PNE型[ PNE type[ | 大鼠表现多动突出,注意力缺陷明显 | 模拟产前尼古丁暴露导致的神经发育异常 | 较优 |
6-OHDA损毁型[ 6-OHDA-lesioned type[ | 大鼠的行为表现复杂,具有年龄、性别差异 | 模拟DA能神经元损伤 | 有限 |
新生缺氧型[ Neonatal hypoxia type[ | 大鼠表现出注意力不集中、冲动 | 模拟缺氧导致的神经损伤 | 有限 |
社会隔离型[ Social isolation type[ | 大鼠表现攻击性反应和冲动、过度活跃,认知功能缺陷 | 伏隔核DA增强,5-羟色胺通路受损 | 有限 |
母性应激型[ Maternal stress type[ | 小鼠表现注意力和学习能力的缺陷 | 产前应激致DA、5-羟色胺网络敏感 | 有限 |
模型名称 Model names | 优点 Advantages | 缺点 Disadvantages | 适用范围 Scopes of application | 应用进展 Application progress |
|---|---|---|---|---|
自发性高血压型[ Spontaneously hyper-tensive type[ | 大鼠多动、注意缺陷典型,药物反应好,易饲养 | 高血压干扰神经指标,雌性数据少,共病焦虑 | ADHD行为学与药理筛选,前额叶-基底节环路研究 | 发现动物双歧杆菌乳亚种A6-肠道菌群-5-羟色胺通路能改善症状 |
无胼胝体鼠种系型[ Acallosal mouse strain type[ | 大鼠的胼胝体缺失模拟人类ADHD患者结构异常,自发多动、注意缺陷 | 神经递质机制不清,表型稳定性待验证 | 脑结构-行为关联,遗传×环境交互研究 | 初步用于基因-行为关联,应用有限 |
DAT-KO型[ DAT-KO type[ | 大鼠DA突触水平升高,表型稳定,托莫西汀反应可预测 | 仅DA系统异常,缺乏社交维度 | DA通路机制,新药靶点验证,突触可塑性研究 | 证实DA过度激活与非典型ADHD表型 |
Lphn3-KO型[ Lphn3-KO type[ | 大鼠编码黏附G蛋白偶联受体L3蛋白的基因缺失,多动冲动明显 | 生长迟缓,性别差异大,预测效度不足 | 编码黏附G蛋白偶联受体L3蛋白的基因功能与神经环路研究 | 初步验证基因缺失导致多动行为 |
Snap25-KO型[ Snap25-KO type[ | 小鼠编码突触相关蛋白25的基因缺失致突触释放障碍,学习记忆缺陷突出 | 眼部畸形干扰行为测试,饲养严格,表型非特异 | 突触功能-认知障碍机制,间接验证ADHD病理 | 支持突触相关蛋白25在学习记忆中的作用 |
NK1R-KO型[ NK1R-KO type[ | 小鼠编码神经激肽1受体的基因缺失,情绪与疼痛调节异常 | 可能共病双相障碍,其他递质代偿 | 情绪调节-疼痛交互,神经激肽1受体拮抗药效评估 | 探索神经激肽1受体-DA通路在情绪注意中的潜力 |
COMT-KO型[ COMT-KO type[ | 小鼠编码儿茶酚-O-甲基转移酶的基因缺失致DA代谢紊乱,认知障碍、多动,性别差异明显 | 环境压力敏感,行为谱覆盖不全 | DA代谢与性别差异机制,应激响应研究 | 揭示了编码儿茶酚-O-甲基转移酶的基因变异在压力诱发ADHD中的作用 |
Fmr1-KO型[ Fmr1-KO type[ | 小鼠模拟脆性X综合征共病ADHD,注意力缺陷明显 | 孤独症谱系障碍特征混杂,对MPH无反应 | 脆性X综合征-ADHD共病机制,智力-注意关联研究 | 揭示智力障碍与注意缺陷的神经关联 |
Med23-CKO型[ Med23-CKO type[ | 小鼠病因明确,核心症状全,对MPH敏感 | 病变限于海马齿状回,未累及多脑区网络 | 组织/阶段特异功能,发育机制研究 | 证实海马结构病变致ADHD样行为,髓鞘缺陷与药效验证 |
环境毒素暴露型[ Environmental toxin exposure type[ | 环境毒素诱导大鼠/小鼠多动/注意缺陷,部分模型药敏好 | 机制多样、难以标准,共病模拟不足 | 环境毒素致病机制,公共卫生风险评估 | 证实拟除虫菊酯破坏DA系统诱导症状 |
PAE型[ PAE type[ | 产前酒精暴露致大鼠腹侧被盖区DA的功能调控异常,MPH可修复电活动 | 剂量周期不一,缺长期病理随访 | 产前酒精对神经发育影响,DA系统机制 | 验证MPH恢复腹侧被盖区神经元功能 |
PNE型[ PNE type[ | 大鼠模拟孕期尼古丁暴露,多动/认知缺陷,性别差异 | 冲动行为模拟不足,与人类吸烟代谢差异 | 基因-环境交互,焦虑/社交共病研究 | 发现κ-阿片受体拮抗剂改善注意力新靶点 |
6-OHDA损毁型[ 6-OHDA-lesioned type[ | 大鼠神经化学同源,行为维度全,药效一致 | 冲动与共病维度不足,DA以外递质未涉及 | 围产期DA损伤,核心症状机制,药效初筛 | 验证传统药物疗效,探索DA缺失长期影响 |
新生缺氧型[ Neonatal hypoxia type[ | 围产期缺氧致大鼠皮层/纹状体萎缩,注意缺陷/冲动 | 物种发育阶段差异,MPH仅提升脑源性神经营养因子 | 围产期脑损伤与ADHD关联,缺氧后神经可塑性 | 研究长期缺氧的神经发育后果 |
社会隔离型[ Social isolation type[ | 早期压力诱导大鼠多动,DA系统高功能,可探索胆碱能机制 | 引起的ADHD样行为在恢复社会环境后可能会逆转 | 早期应激对ADHD发病机制,药物作用途径扩展 | 发现MPH经胆碱能系统改善认知的新机制 |
母性应激型[ Maternal stress type[ | 小鼠模拟人类孕期应激,再现注意、学习缺陷,关联DA/5-羟色胺网络 | 应激强度难标准化 | 产前应激-神经发育关联,DA能药物评估 | 验证DA拮抗剂对运动亢进的抑制作用 |
表 2 各种注意缺陷多动障碍动物模型的研究特性及应用对比
Table 2 Research characteristics and application comparison of various animal models of attention deficit and hyperactive disorder
模型名称 Model names | 优点 Advantages | 缺点 Disadvantages | 适用范围 Scopes of application | 应用进展 Application progress |
|---|---|---|---|---|
自发性高血压型[ Spontaneously hyper-tensive type[ | 大鼠多动、注意缺陷典型,药物反应好,易饲养 | 高血压干扰神经指标,雌性数据少,共病焦虑 | ADHD行为学与药理筛选,前额叶-基底节环路研究 | 发现动物双歧杆菌乳亚种A6-肠道菌群-5-羟色胺通路能改善症状 |
无胼胝体鼠种系型[ Acallosal mouse strain type[ | 大鼠的胼胝体缺失模拟人类ADHD患者结构异常,自发多动、注意缺陷 | 神经递质机制不清,表型稳定性待验证 | 脑结构-行为关联,遗传×环境交互研究 | 初步用于基因-行为关联,应用有限 |
DAT-KO型[ DAT-KO type[ | 大鼠DA突触水平升高,表型稳定,托莫西汀反应可预测 | 仅DA系统异常,缺乏社交维度 | DA通路机制,新药靶点验证,突触可塑性研究 | 证实DA过度激活与非典型ADHD表型 |
Lphn3-KO型[ Lphn3-KO type[ | 大鼠编码黏附G蛋白偶联受体L3蛋白的基因缺失,多动冲动明显 | 生长迟缓,性别差异大,预测效度不足 | 编码黏附G蛋白偶联受体L3蛋白的基因功能与神经环路研究 | 初步验证基因缺失导致多动行为 |
Snap25-KO型[ Snap25-KO type[ | 小鼠编码突触相关蛋白25的基因缺失致突触释放障碍,学习记忆缺陷突出 | 眼部畸形干扰行为测试,饲养严格,表型非特异 | 突触功能-认知障碍机制,间接验证ADHD病理 | 支持突触相关蛋白25在学习记忆中的作用 |
NK1R-KO型[ NK1R-KO type[ | 小鼠编码神经激肽1受体的基因缺失,情绪与疼痛调节异常 | 可能共病双相障碍,其他递质代偿 | 情绪调节-疼痛交互,神经激肽1受体拮抗药效评估 | 探索神经激肽1受体-DA通路在情绪注意中的潜力 |
COMT-KO型[ COMT-KO type[ | 小鼠编码儿茶酚-O-甲基转移酶的基因缺失致DA代谢紊乱,认知障碍、多动,性别差异明显 | 环境压力敏感,行为谱覆盖不全 | DA代谢与性别差异机制,应激响应研究 | 揭示了编码儿茶酚-O-甲基转移酶的基因变异在压力诱发ADHD中的作用 |
Fmr1-KO型[ Fmr1-KO type[ | 小鼠模拟脆性X综合征共病ADHD,注意力缺陷明显 | 孤独症谱系障碍特征混杂,对MPH无反应 | 脆性X综合征-ADHD共病机制,智力-注意关联研究 | 揭示智力障碍与注意缺陷的神经关联 |
Med23-CKO型[ Med23-CKO type[ | 小鼠病因明确,核心症状全,对MPH敏感 | 病变限于海马齿状回,未累及多脑区网络 | 组织/阶段特异功能,发育机制研究 | 证实海马结构病变致ADHD样行为,髓鞘缺陷与药效验证 |
环境毒素暴露型[ Environmental toxin exposure type[ | 环境毒素诱导大鼠/小鼠多动/注意缺陷,部分模型药敏好 | 机制多样、难以标准,共病模拟不足 | 环境毒素致病机制,公共卫生风险评估 | 证实拟除虫菊酯破坏DA系统诱导症状 |
PAE型[ PAE type[ | 产前酒精暴露致大鼠腹侧被盖区DA的功能调控异常,MPH可修复电活动 | 剂量周期不一,缺长期病理随访 | 产前酒精对神经发育影响,DA系统机制 | 验证MPH恢复腹侧被盖区神经元功能 |
PNE型[ PNE type[ | 大鼠模拟孕期尼古丁暴露,多动/认知缺陷,性别差异 | 冲动行为模拟不足,与人类吸烟代谢差异 | 基因-环境交互,焦虑/社交共病研究 | 发现κ-阿片受体拮抗剂改善注意力新靶点 |
6-OHDA损毁型[ 6-OHDA-lesioned type[ | 大鼠神经化学同源,行为维度全,药效一致 | 冲动与共病维度不足,DA以外递质未涉及 | 围产期DA损伤,核心症状机制,药效初筛 | 验证传统药物疗效,探索DA缺失长期影响 |
新生缺氧型[ Neonatal hypoxia type[ | 围产期缺氧致大鼠皮层/纹状体萎缩,注意缺陷/冲动 | 物种发育阶段差异,MPH仅提升脑源性神经营养因子 | 围产期脑损伤与ADHD关联,缺氧后神经可塑性 | 研究长期缺氧的神经发育后果 |
社会隔离型[ Social isolation type[ | 早期压力诱导大鼠多动,DA系统高功能,可探索胆碱能机制 | 引起的ADHD样行为在恢复社会环境后可能会逆转 | 早期应激对ADHD发病机制,药物作用途径扩展 | 发现MPH经胆碱能系统改善认知的新机制 |
母性应激型[ Maternal stress type[ | 小鼠模拟人类孕期应激,再现注意、学习缺陷,关联DA/5-羟色胺网络 | 应激强度难标准化 | 产前应激-神经发育关联,DA能药物评估 | 验证DA拮抗剂对运动亢进的抑制作用 |
| [1] | 李雪军, 王淑敏, 姜之炎, 等. 注意缺陷多动障碍模型及其病理机制研究进展[J]. 中国比较医学杂志, 2023, 33(5):145-152. DOI:10.3969/j.issn.1671-7856.2023.05.018 . |
| LI X J, WANG S M, JIANG Z Y, et al. Research progress on models and pathological mechanisms of attention deficit hyperactivity disorder[J]. Chin J Comp Med, 2023, 33(5):145-152. DOI:10.3969/j.issn.1671-7856.2023.05.018 . | |
| [2] | 卓利楠, 曾祥玉, 吴冰, 等. 内侧前额皮层-伏隔核环路在决策冲动中的作用: 基于动物模型的研究[J]. 心理学报, 2023, 55(4):556-571. |
| ZHUO L N, ZENG X Y, WU B, et al. The function of mPFC-NAc circuit in decision impulsivity: a study based on an animal model[J]. Acta Psychol Sin, 2023, 55(4):556-571. | |
| [3] | YOUNG S, UYSAL O, KAHLE J, et al. A systematic review and meta-analysis comparing the severity of core symptoms of attention-deficit hyperactivity disorder in females and males[J]. Psychol Med, 2024, 54(14):1-22. DOI:10.1017/S0033291724001600 . |
| [4] | LI F H, CUI Y H, LI Y, et al. Prevalence of mental disorders in school children and adolescents in China: diagnostic data from detailed clinical assessments of 17, 524 individuals[J]. J Child Psychol Psychiatry, 2022, 63(1): 34-46. DOI: 10.1111/jcpp. 13445 . |
| [5] | SATO T, SCHRECKENBERG R, SCHLÜTER K D. Attention-deficit hyperactivity disorder in spontaneously hypertensive rat strain SHR/NCrl is associated with specific expression of uncoupling proteins, glucose transporter 1 and BACE1[J]. Front Cell Neurosci, 2025, 19: 1612751. DOI: 10.3389/fncel. 2025. 1612751 . |
| [6] | 周荣易, 王娇娇, 韩新民. SHR、WKY大鼠与SD大鼠注意缺陷多动障碍模型行为学特征的比较[J]. 中国实验动物学报, 2017, 25(4): 380-385. DOI:10.3969/j.issn.1005-4847.2017.04.007 . |
| ZHOU R Y, WANG J J, HAN X M. Comparison of the behavior characteristics in SHR, WKY and SD rat models of attention deficit/hyperactivity disorder[J]. Acta Lab Anim Sci Sin, 2017, 25(4): 380-385. DOI:10.3969/j.issn.1005-4847.2017.04.007 . | |
| [7] | GONZÁLEZ-BARRIGA F, ORDUÑA V. Incentive-salience attribution is attenuated in spontaneously hypertensive rats, an animal model of ADHD[J]. Behav Processes, 2024, 220: 105068. DOI: 10.1016/j.beproc.2024.105068 . |
| [8] | DELA PEÑA I, DELA PEÑA I J, DE LA PEÑA J B, et al. Methylphenidate and atomoxetine-responsive prefrontal cortical genetic overlaps in "impulsive" SHR/NCrl and wistar rats[J]. Behav Genet, 2017, 47(5): 564-580. DOI:10.1007/s10519-017-9861-3 . |
| [9] | BOGDAŃSKA-CHOMCZYK E, WOJTACHA P, TSAI M L, et al. Alterations in striatal architecture and biochemical markers' levels during postnatal development in the rat model of an attention deficit/hyperactivity disorder (ADHD)[J]. Int J Mol Sci, 2024, 25(24): 13652. DOI:10.3390/ijms252413652 . |
| [10] | SHAH P M, PILLARELLA N R, TELATIN M, et al. Alcohol withdrawal and amphetamine co-use in an animal model for attention deficit hyperactivity disorder[J]. Am J Drug Alcohol Abuse, 2024, 50(3): 334-344. DOI:10.1080/00952990.2024.2349885 . |
| [11] | MATSUZAKI K, SUGIMOTO N, HOSSAIN S, et al. Theobromine improves hyperactivity, inattention, and working memory via modulation of dopaminergic neural function in the frontal cortex of spontaneously hypertensive rats[J]. Food Funct, 2024, 15(10): 5579-5595. DOI: 10.1039/d4fo00683f . |
| [12] | YIN X D, LIU W C, FENG H H, et al. Bifidobacterium animalis subsp. lactis A6 attenuates hippocampal damage and memory impairments in an ADHD rat model[J]. Food Funct, 2024, 15(5): 2668-2678. DOI: 10.1039/d3fo04665f . |
| [13] | LONG Y J, PAN N F, JI S Y, et al. Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: a comparative meta-analysis[J]. Transl Psychiatry, 2022, 12(1): 368. DOI: 10.1038/s41398-022-02130-6 . |
| [14] | MAMEDOVA D I, NEDOGREEVA O A, MANOLOVA A O, et al. The impact of long-term isolation on anxiety, depressive-like and social behavior in aging Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) male rats[J]. Sci Rep, 2024, 14(1): 28135. DOI: 10.1038/s41598-024-79677-5 . |
| [15] | ZHANG P, FANG H Y, LOU C J, et al. Enhanced glial reaction and altered neuronal nitric oxide synthase are implicated in attention deficit hyperactivity disorder[J]. Front Cell Dev Biol, 2022, 10: 901093. DOI: 10.3389/fcell.2022.901093 . |
| [16] | TOSTA A, FONSECA A S, MESSEDER D, et al. Effects of gestational exercise on nociception, BDNF, and irisin levels in an animal model of ADHD[J]. Neuroscience, 2024, 543: 37-48. DOI: 10.1016/j.neuroscience.2024.02.008 . |
| [17] | XIONG Y R, YANG L Y, WANG C T, et al. Cortical mapping of callosal connections in healthy young adults[J]. Hum Brain Mapp, 2024, 45(3): e26629. DOI: 10.1002/hbm.26629 . |
| [18] | YU M M, GAO X Y, NIU X Y, et al. Meta-analysis of structural and functional alterations of brain in patients with attention-deficit/hyperactivity disorder[J]. Front Psychiatry, 2023, 13: 1070142. DOI: 10.3389/fpsyt.2022.1070142 . |
| [19] | SRIVASTAVA D K, NAVRATNA V, TOSH D K, et al. Structure of the human dopamine transporter and mechanisms of inhibition[J]. Nature, 2024, 632(8025): 672-677. DOI: 10.1038/s41586-024-07739-9 . |
| [20] | REINWALD J R, GASS N, MALLIEN A S, et al. Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits[J]. Mol Psychiatry, 2022, 27(4): 2329-2339. DOI: 10.1038/s41380-022-01471-4 . |
| [21] | ZELLI S, BRANCATO A, MATTIOLI F, et al. A new "sudden fright paradigm" to explore the role of (epi)genetic modulations of the DAT gene in fear-induced avoidance behavior[J]. Genes Brain Behav, 2021, 20(4): e12709. DOI: 10. 1111/gbb.12709 . |
| [22] | PTUKHA M, FESENKO Z, BELSKAYA A, et al. Effects of atomoxetine on motor and cognitive behaviors and brain electrophysiological activity of dopamine transporter knockout rats[J]. Biomolecules, 2022, 12(10): 1484. DOI: 10. 3390/biom12101484 . |
| [23] | CICHERO E, FRANCESCONI V, CASINI B, et al. Discovery of guanfacine as a novel TAAR1 agonist: a combination strategy through molecular modeling studies and biological assays[J]. Pharmaceuticals, 2023, 16(11): 1632. DOI: 10.3390/ph16111632 . |
| [24] | SAVCHENKO A, TARGA G, FESENKO Z, et al. Dopamine transporter deficient rodents: perspectives and limitations for neuroscience[J]. Biomolecules, 2023, 13(5): 806. DOI: 10. 3390/biom13050806 . |
| [25] | LEO D, SUKHANOV I, ZORATTO F, et al. Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats[J]. J Neurosci, 2018, 38(8): 1959-1972. DOI: 10.1523/JNEUROSCI. 1931-17.2018 . |
| [26] | KURZINA N P, ARISTOVA I Y, VOLNOVA A B, et al. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze[J]. Behav Brain Res, 2020, 390: 112642. DOI: 10.1016/j.bbr.2020.112642 . |
| [27] | ADINOLFI A, ZELLI S, LEO D, et al. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system[J]. Behav Brain Res, 2019, 359: 516-527. DOI: 10.1016/j.bbr.2018.11.028 . |
| [28] | HARRIS S S, GREEN S M, KUMAR M, et al. A role for cortical dopamine in the paradoxical calming effects of psychostimulants[J]. Sci Rep, 2022, 12(1): 3129. DOI: 10.1038/s41598-022-07029-2 . |
| [29] | MORENO-SALINAS A L, HOLLERAN B J, OJEDA-MUÑIZ E Y, et al. Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility[J]. Mol Psychiatry, 2022, 27(5): 2425-2438. DOI: 10.1038/s41380-022-01537-3 . |
| [30] | REGAN S L, HUFGARD J R, PITZER E M, et al. Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers[J]. Neurobiol Dis, 2019, 130: 104494. DOI: 10.1016/j.nbd.2019.104494 . |
| [31] | SABLE H J K, LESTER D B, POTTER J L, et al. An assessment of executive function in two different rat models of attention-deficit hyperactivity disorder: Spontaneously hypertensive versus Lphn3 knockout rats[J]. Genes Brain Behav, 2021, 20(8): e12767. DOI: 10.1111/gbb.12767 . |
| [32] | VAN DER VOET M, HARICH B, FRANKE B, et al. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila [J]. Mol Psychiatry, 2016, 21(4): 565-573. DOI: 10. 1038/mp.2015.55 . |
| [33] | CERVANTES-HENRÍQUEZ M L, ACOSTA-LÓPEZ J E, MARTINEZ A F, et al. Machine learning prediction of ADHD severity: association and linkage to ADGRL3, DRD4, and SNAP25[J]. J Atten Disord, 2022, 26(4): 587-605. DOI: 10.1177/10870547211015426 . |
| [34] | IRFAN M, GOPAUL K R, MIRY O, et al. SNAP-25 isoforms differentially regulate synaptic transmission and long-term synaptic plasticity at central synapses[J]. Sci Rep, 2019, 9(1): 6403. DOI: 10.1038/s41598-019-42833-3 . |
| [35] | HUANG M J, CHOW C H, GURDITA A, et al. SNAP-25, but not SNAP-23, is essential for photoreceptor development, survival, and function in mice[J]. Commun Biol, 2024, 7(1): 34. DOI: 10. 1038/s42003-023-05760-8 . |
| [36] | KIM D, YADAV D, SONG M. An updated review on animal models to study attention-deficit hyperactivity disorder[J]. Transl Psychiatry, 2024, 14(1): 187. DOI: 10.1038/s41398-024-02893-0 . |
| [37] | PORTER A J, PILLIDGE K, STANFORD S C, et al. Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5-Choice Continuous Performance Test[J]. Behav Brain Res, 2016, 298(Pt B): 268-277. DOI: 10.1016/j.bbr. 2015. 10.045 . |
| [38] | PILLIDGE K, PORTER A J, YOUNG J W, et al. Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test[J]. J Psychopharmacol, 2016, 30(9): 837-847. DOI: 10.1177/0269881116642541 . |
| [39] | PILLIDGE K, PORTER A J, VASILI T, et al. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice[J]. Pharmacol Biochem Behav, 2014, 127: 56-61. DOI: 10.1016/j.pbb.2014.10.008 . |
| [40] | YAN T C, DUDLEY J A, WEIR R K, et al. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day[J]. PLoS One, 2011, 6(3): e17586. DOI: 10.1371/journal.pone.0017586 . |
| [41] | SHARP S I, MCQUILLIN A, MARKS M, et al. Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome[J]. Am J Med Genet B Neuropsychiatr Genet, 2014, 165B(4): 373-380. DOI: 10.1002/ajmg.b.32241 . |
| [42] | SCHANK J R. Neurokinin receptors in drug and alcohol addiction[J]. Brain Res, 2020, 1734: 146729. DOI: 10.1016/j.brainres.2020.146729 . |
| [43] | PAPALEO F, ERICKSON L, LIU G P, et al. Effects of sex and COMT genotype on environmentally modulated cognitive control in mice[J]. Proc Natl Acad Sci USA, 2012, 109(49): 20160-20165. DOI: 10.1073/pnas.1214397109 . |
| [44] | KÄENMÄKI M, TAMMIMÄKI A, MYÖHÄNEN T, et al. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice[J]. J Neurochem, 2010, 114(6): 1745-1755. DOI: 10.1111/j.1471-4159.2010.06889.x . |
| [45] | CREGENZÁN-ROYO O, BRUN-GASCA C, FORNIELES-DEU A. Behavior problems and social competence in fragile X syndrome: a systematic review[J]. Genes, 2022, 13(2): 280. DOI: 10.3390/genes13020280 . |
| [46] | GOLDEN C E M, BREEN M S, KORO L, et al. Deletion of the KH1 domain of Fmr1 leads to transcriptional alterations and attentional deficits in rats[J]. Cereb Cortex, 2019, 29(5): 2228-2244. DOI: 10.1093/cercor/bhz029 . |
| [47] | GOLDEN C E M, YEE Y, WANG V X, et al. Reduced axonal caliber and structural changes in a rat model of Fragile X syndrome with a deletion of a K-Homology domain of Fmr1[J]. Transl Psychiatry, 2020, 10: 280. DOI: 10.1038/s41398-020-00943-x . |
| [48] | LOZANO R, ROSERO C A, HAGERMAN R J. Fragile X spectrum disorders[J]. Intractable Rare Dis Res, 2014, 3(4):134-146. DOI:10.5582/irdr.2014.01022 . |
| [49] | BOYLE L, KAUFMANN W E. The behavioral phenotype of FMR1 mutations[J]. Am J Med Genet C Semin Med Genet, 2010, 154C(4):469-476. DOI:10.1002/ajmg.c.30277 . |
| [50] | NTOULAS G, BRAKATSELOS C, NAKAS G, et al. Multi-level profiling of the Fmr1 KO rat unveils altered behavioral traits along with aberrant glutamatergic function[J]. Transl Psychiatry, 2024, 14(1):104. DOI:10.1038/s41398-024-02815-0 . |
| [51] | ZAFARULLAH M, TASSONE F. Molecular biomarkers in fragile X syndrome[J]. Brain Sci, 2019, 9(5):96. DOI:10.3390/brainsci9050096 . |
| [52] | HASHIMOTO S, BOISSEL S, ZARHRATE M, et al. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression[J]. Science, 2011, 333(6046): 1161-1163. DOI: 10.1126/science.1206638 . |
| [53] | ZHOU B Y, LI Z X, LI Y W, et al. Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice[J]. Neuropsychopharmacology, 2025, 50(8):1224-1236. DOI:10.1038/s41386-025-02088-1 . |
| [54] | SHVACHIY L, AMARO-LEAL Â, OUTEIRO T F, et al. From molecular to functional effects of different environmental lead exposure paradigms[J]. Biology, 2022, 11(8): 1164. DOI: 10. 3390/biology11081164 . |
| [55] | SPROWLES J L N, AMOS-KROOHS R M, BRAUN A A, et al. Developmental manganese, lead, and barren cage exposure have adverse long-term neurocognitive, behavioral and monoamine effects in Sprague-Dawley rats[J]. Neurotoxicol Teratol, 2018, 67:50-64. DOI:10.1016/j.ntt.2018.04.001 . |
| [56] | REGAN S L, WILLIAMS M T, VORHEES C V. Review of rodent models of attention deficit hyperactivity disorder[J]. Neurosci Biobehav Rev, 2022, 132:621-637. DOI:10.1016/j.neubiorev. 2021.11.041 . |
| [57] | PITZER E M, WILLIAMS M T, VORHEES C V. Effects of pyrethroids on brain development and behavior: Deltamethrin[J]. Neurotoxicol Teratol, 2021, 87: 106983. DOI: 10.1016/j.ntt. 2021.106983 . |
| [58] | SMITH D R, STRUPP B J. Animal models of childhood exposure to lead or manganese: evidence for impaired attention, impulse control, and affect regulation and assessment of potential therapies[J]. Neurotherapeutics, 2023, 20(1):3-21. DOI:10.1007/s13311-023-01345-9 . |
| [59] | WANG R X, MARTIN C D, LEI A L, et al. Prenatal ethanol exposure leads to attention deficits in both male and female rats[J]. Front Neurosci, 2020, 14: 12. DOI: 10.3389/fnins. 2020. 00012 . |
| [60] | WANG J, HAJ-DAHMANE S, SHEN R Y. Effects of prenatal ethanol exposure on the excitability of ventral tegmental area dopamine neurons in vitro [J]. J Pharmacol Exp Ther, 2006, 319(2):857-863. DOI:10.1124/jpet.106.109041 . |
| [61] | LOUTH E L, BIGNELL W, TAYLOR C L, et al. Developmental ethanol exposure leads to long-term deficits in attention and its underlying prefrontal circuitry[J]. eNeuro, 2016, 3(5):ENEURO.0267-16.2016. DOI:10.1523/ENEURO.0267-16.2016 . |
| [62] | ROJAS-MAYORQUÍN A E, PADILLA-VELARDE E, ORTUÑO-SAHAGÚN D. Prenatal alcohol exposure in rodents as a promising model for the study of ADHD molecular basis[J]. Front Neurosci, 2016, 10:565. DOI:10.3389/fnins.2016.00565 . |
| [63] | CHOONG K C, SHEN R Y. Methylphenidate restores ventral tegmental area dopamine neuron activity in prenatal ethanol-exposed rats by augmenting dopamine neurotransmission[J]. J Pharmacol Exp Ther, 2004, 309(2):444-451. DOI:10.1124/jpet.103.060657 . |
| [64] | SHARMA N, LUHACH K, GOLANI L K, et al. Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorder[J]. Alcohol, 2022, 105: 25-34. DOI: 10.1016/j.alcohol. 2022.08.005 . |
| [65] | LIU D, REN Y P, WU T F, et al. Parental smoking exposure before and during pregnancy and offspring attention-deficit/hyperactivity disorder risk: a Chinese child and adolescent cohort study[J]. Front Public Health, 2022, 10:1017046. DOI:10.3389/fpubh.2022.1017046 . |
| [66] | ZHANG L, SPENCER T J, BIEDERMAN J, et al. Attention and working memory deficits in a perinatal nicotine exposure mouse model[J]. PLoS One, 2018, 13(5): e0198064. DOI:10.1371/journal.pone.0198064 . |
| [67] | ZHOU M Y, QIU W, OHASHI N, et al. Deep-learning-based analysis reveals a social behavior deficit in mice exposed prenatally to nicotine[J]. Cells, 2024, 13(3):275. DOI:10.3390/cells13030275 . |
| [68] | ZHU J M, ZHANG X, XU Y H, et al. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment[J]. J Neurosci, 2012, 32(27):9410-9418. DOI:10.1523/JNEUROSCI. 1041-12.2012 . |
| [69] | PIÑA R, ROZAS C, CONTRERAS D, et al. Atomoxetine reestablishes long term potentiation in a mouse model of attention deficit/hyperactivity disorder[J]. Neuroscience, 2020, 439: 268-274. DOI: 10.1016/j.neuroscience.2019.10.040 . |
| [70] | CONTRERAS D, PIÑA R, CARVALLO C, et al. Methylphenidate restores behavioral and neuroplasticity impairments in the prenatal nicotine exposure mouse model of ADHD: evidence for involvement of AMPA receptor subunit composition and synaptic spine morphology in the hippocampus[J]. Int J Mol Sci, 2022, 23(13): 7099. DOI: 10. 3390/ijms23137099 . |
| [71] | ZHANG L, MCCARTHY D M, ESKOW JAUNARAJS K L, et al. Frontal cortical monoamine release, attention, and working memory in a perinatal nicotine exposure mouse model following kappa opioid receptor antagonism[J]. Cereb Cortex, 2021, 31(1):483-496. DOI:10.1093/cercor/bhaa238 . |
| [72] | BOUCHATTA O, MANOUZE H, BOUALI-BENAZZOUZ R, et al. Neonatal 6-OHDA lesion model in mouse induces Attention-Deficit/Hyperactivity Disorder (ADHD)-like behaviour[J]. Sci Rep, 2018, 8(1):15349. DOI:10.1038/s41598-018-33778-0 . |
| [73] | MESEGUER-BELTRÁN M, SÁNCHEZ-SARASÚA S, LANDRY M, et al. Targeting neuroinflammation with abscisic acid reduces pain sensitivity in females and hyperactivity in males of an ADHD mice model[J]. Cells, 2023, 12(3): 465. DOI: 10. 3390/cells12030465 . |
| [74] | KOSTRZEWA J P, KOSTRZEWA R A, KOSTRZEWA R M, et al. Perinatal 6-hydroxydopamine modeling of ADHD[J]. Curr Top Behav Neurosci, 2016, 29:279-293. DOI: 10.1007/7854_2015_397 . |
| [75] | LEE W S, YOON B E. Necessity of an integrative animal model for a comprehensive study of attention-deficit/hyperactivity disorder[J]. Biomedicines, 2023, 11(5): 1260. DOI: 10.3390/biomedicines11051260 . |
| [76] | WANG B, ZENG H T, LIU J L, et al. Effects of prenatal hypoxia on nervous system development and related diseases[J]. Front Neurosci, 2021, 15:755554. DOI:10.3389/fnins.2021.755554 . |
| [77] | MIGUEL P M, SCHUCH C P, ROJAS J J, et al. Neonatal hypoxia-ischemia induces attention-deficit hyperactivity disorder-like behavior in rats[J]. Behav Neurosci, 2015, 129(3):309-320. DOI:10.1037/bne0000063 . |
| [78] | MIGUEL P M, DENIZ B F, CONFORTIM H D, et al. Methylphenidate treatment increases hippocampal BDNF levels but does not improve memory deficits in hypoxic-ischemic rats[J]. J Psychopharmacol, 2020, 34(7):750-758. DOI:10.1177/0269881120913153 . |
| [79] | 井贺云, 康乐, 董亚博, 等. 注意力缺陷多动障碍啮齿类动物模型中西医研究新进展[J]. 中国实验方剂学杂志, 2024, 30(15):280-289. DOI:10.13422/j.cnki.syfjx.20240429 . |
| JING H Y, KANG L, DONG Y B, et al. Rodent models of attention deficit hyperactivity disorder: a review based on Chinese and western medicine[J]. Chin J Exp Tradit Med Formulae, 2024, 30(15):280-289. DOI:10.13422/j.cnki.syfjx.20240429 . | |
| [80] | MATSUMOTO K, ONO K, OUCHI H, et al. Social isolation stress down-regulates cortical early growth response 1 (Egr-1) expression in mice[J]. Neurosci Res, 2012, 73(3):257-262. DOI:10.1016/j.neures.2012.04.004 . |
| [81] | FONE K C F, VERONICA PORKESS M V. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders[J]. Neurosci Biobehav Rev, 2008, 32(6):1087-1102. DOI:10.1016/j.neubiorev.2008.03.003 . |
| [82] | 谢新月, 刘晓绵, 李铭, 等. 基于中西医临床病证特点的注意缺陷多动障碍动物模型的临床吻合度分析[J]. 中国实验方剂学杂志, 2025, 31(13):270-278. DOI:10.13422/j.cnki.syfjx.20241317 . |
| XIE X Y, LIU X M, LI M, et al. Analysis of clinical consistency of animal models of attention deficit hyperactivity disorder based on characteristics of clinical diseases and syndromes in traditional Chinese and western medicine[J]. Chin J Exp Tradit Med Formulae, 2025, 31(13):270-278. DOI:10.13422/j.cnki.syfjx.20241317 . | |
| [83] | JALLOW J, HURTIG T, KERKELÄ M, et al. Prenatal maternal stress, breastfeeding and offspring ADHD symptoms[J]. Eur Child Adolesc Psychiatry, 2024, 33(11):4003-4011. DOI:10.1007/s00787-024-02451-5 . |
| [84] | HARPER K M, HARP S J, MOY S S. Prenatal stress unmasks behavioral phenotypes in genetic mouse models of neurodevelopmental disorders[J]. Front Behav Neurosci, 2023, 17:1271225. DOI:10.3389/fnbeh.2023.1271225 . |
| [85] | RADHAKRISHNAN A, ASWATHY B S, KUMAR V M, et al. Sleep deprivation during late pregnancy produces hyperactivity and increased risk-taking behavior in offspring[J]. Brain Res, 2015, 1596:88-98. DOI:10.1016/j.brainres.2014.11.021 . |
| [86] | 赵奚玉, 张天宇, 王子, 等. 基于中西医临床病证特点的注意力缺陷多动障碍动物模型评价分析[J/OL]. 中药药理与临床, 2025:1-27[2025-02-19]. . |
| ZHAO X Y, ZHANG T Y, WANG Z, et al. Evaluation and analysis of animal models of attention deficit hyperactivity disorder based on characteristics of clinical symptoms of traditional Chinese and western medicine[J/OL]. Pharmacol Clin Chin Mater Med, 2025:1-27[2025-02-19]. . |
| [1] | 刘畅, 项雪松, 贺辉煌, 陈晓青, 邱文洪. 2,4-二硝基氟苯诱导特应性皮炎氧化应激模型的建立及评价[J]. 实验动物与比较医学, 2026, 46(1): 46-54. |
| [2] | 徐波, 陈泰任, 方乾, 吴际. 脊髓压迫和半横断损伤小鼠模型的时空基因表达谱及修复机制研究[J]. 实验动物与比较医学, 2026, 46(1): 32-45. |
| [3] | 杨琳, 金梦, 吴汗青, 李顺, 周晓辉. 痘苗病毒天坛株感染AG6小鼠脑病模型的建立与初步分析[J]. 实验动物与比较医学, 2026, 46(1): 3-10. |
| [4] | 徐英韬, 王蒙蒙, 林平, 迟海涛, 王怡, 白鹰. 外泌体通过NRF2/SLC7A11/GPX4通路调控铁死亡治疗小鼠缺血性脑卒中[J]. 实验动物与比较医学, 2026, 46(1): 20-31. |
| [5] | 孙强. FDA新政下减少非人灵长类实验动物使用量的可行路径[J]. 实验动物与比较医学, 2026, 46(1): 149-152. |
| [6] | 郑卿勇, 周泳佳, 李腾飞, 许建国, 田晨, 刘辉, 田敏, 周姿余, 徐彩花, 崔雅婷, 王俊斐, 田金徽. 动物实验评价指标体系标准化问题与核心指标集构建策略思考[J]. 实验动物与比较医学, 2026, 46(1): 138-148. |
| [7] | 李晓琴, 余文兰, 段依竺, 刘忠华, 吴国栋, 史文琦, 富宏坤. 中国实验动物科技伦理治理体系构建与广东省实践初探[J]. 实验动物与比较医学, 2026, 46(1): 127-137. |
| [8] | 肖芳平, 熊莉娟, 贾菠, 刘欢, 罗勇兵, 万筱荣. 2020—2024年江西省实验动物的微生物、寄生虫检测结果分析[J]. 实验动物与比较医学, 2026, 46(1): 119-126. |
| [9] | 何家祺, 周园园, 聂永强, 王朝霞, 徐汪节. 香烟烟雾暴露诱导慢性阻塞性肺疾病小鼠模型的构建及多维度病理评估[J]. 实验动物与比较医学, 2026, 46(1): 11-19. |
| [10] | 王晗玥, 陈嘉玮, 高湘滨, 罗威, 刘素宁. 黑腹果蝇心侧体功能的研究概述[J]. 实验动物与比较医学, 2025, 45(6): 705-718. |
| [11] | 贠佳琦, 马芹, 王官栋, 孙佩璐, 王义冠, 王四宝. 基因驱动技术在蚊媒疾病防控中的研究进展与挑战[J]. 实验动物与比较医学, 2025, 45(6): 773-783. |
| [12] | 盛李宏. 跳镰猛蚁:解码社会行为与衰老可塑性的模型昆虫[J]. 实验动物与比较医学, 2025, 45(6): 762-772. |
| [13] | 宋梦娇, 沈义栋. 秀丽隐杆线虫的线粒体形态和功能研究方法及应用实例[J]. 实验动物与比较医学, 2025, 45(6): 726-737. |
| [14] | 周冠宇, 朱仕明, 刘方方. 美洲大蠊作为实验用动物模型的研究进展[J]. 实验动物与比较医学, 2025, 45(6): 794-802. |
| [15] | 刘松, 莫倩茹, 王瑾, 崔颖, 田铃. 黑水虻的主要生物学特性及其作为模式生物的开发应用前景[J]. 实验动物与比较医学, 2025, 45(6): 803-809. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||